News
More states, territories and Washington, D.C., have signed on to a settlement with drugmaker Purdue Pharma and the Sackler family over the opioid crisis, officials said.
A judge intends to rule this week on a plan for local governments and individual victims to vote on OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the toll of opioids.
The Sackler family will now relinquish control of Purdue Pharma and cease sale of opioids in the U.S. as part of a $7.4 ...
A judge could decide Friday whether to advance OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of ...
All eligible U.S. states and territories have agreed to sign a $7.4 billion settlement with the company and family behind ...
Oxycontin maker Purdue Pharma received court approval on Friday to begin voting on its $7.4 billion bankruptcy settlement, ...
The deal ends the Sackler family's ownership of the company and bans them from ever selling opioids in the U.S. again.
Purdue Pharma to pay $7.4 billion in opioid lawsuit settlement - Besides the hefty financial reward, the settlement also ends ...
Purdue Pharma may settle $7 billion with government entities, emergency room doctors, insurers, and families of children born ...
Purdue Pharma, the maker of Oxycontin, conducted what may be the most extensive investigation yet of the Sackler family, exploring whether they committed crimes or financial improprieties, ...
Purdue Pharma, the maker of OxyContin, pleaded guilty Tuesday to three federal criminal charges related to the company’s role in creating the nation’s opioid crisis.
A judge has advanced OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results